Viewing Study NCT00333034


Ignite Creation Date: 2025-12-25 @ 2:35 AM
Ignite Modification Date: 2025-12-26 @ 1:12 AM
Study NCT ID: NCT00333034
Status: COMPLETED
Last Update Posted: 2007-12-06
First Post: 2006-05-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-06
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2007-05
Completion Date Type: ACTUAL
First Submit Date: 2006-05-23
First Submit QC Date: None
Study First Post Date: 2006-06-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2007-12-04
Last Update Post Date: 2007-12-06
Last Update Post Date Type: ESTIMATED